2023 Annual Meeting | S1 - Global Health

Date Sunday 04/23/23

Time 01:00 PM - 01:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Bridgette J. Billioux, MD, Allison P. Navis, MD

Topic(s) Global Health and Neuroepidemiology

Learning Objectives A group of abstracts covering a similar topic presented in an oral format. Presentaons are eight minutes in length with four minutes for queson and answer with the author.

CME Available 0.75 CME credit

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:12 PM EST	Abstract	001 - Impact of a Free Anti-seizure Medication Intervention on Anxiety and Depression in People Living with Epilepsy in the Republic of Guinea Dylan R. Rice
01:12 PM - 01:24 PM EST	Abstract	002 - Stroke Epidemiology Among Young Adults with Stroke in Zambia Aparna Nutakki, MD
01:24 PM - 01:36 PM EST	Abstract	003 - Evaluation of the Public Health Surveillance System for Bacterial Meningitis in Colombia Gabriel D. Pinilla Monsalve, MD, MSc

Faculty Disclosures
Deanna Saylor, MD, MHS	The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Gabriel D. Pinilla Monsalve, MD, MSc	Dr. Pinilla Monsalve has nothing to disclose.
Mashina Chomba, MBChB	Dr. Chomba has nothing to disclose.
Aparna Nutakki, MD	Ms. Nutakki has received research support from UJMT Fogarty Global Health Fellowship Program. Ms. Nutakki has received research support from AAN Medical Student Research Scholarship. Ms. Nutakki has received research support from Gold Humanism Student Summer Fellowship.
Guelngar Carlos Othon, Jr., MD	Guelngar Carlos Othon has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics.
	No disclosure on file
Nathanael J. Lee, MD, PhD	Dr. Lee has nothing to disclose.
Stanley Zimba, MBBS	Dr. Zimba has nothing to disclose.
Lorraine Chishimba, MBChB, MMED	Dr. Chishimba has nothing to disclose.
Dylan R. Rice	Mr. Rice has nothing to disclose.
Bridgette J. Billioux, MD	Dr. Billioux has nothing to disclose.
Allison P. Navis, MD	The institution of Dr. Navis has received research support from NIH Loan Repayment Program.